Evidence map›Paper›PMID 31555945›Full record

ArticleClinical & experimental metastasis2020

The prognostic value of PET/CT evaluation with Deauville score on the recurrence and survival in diffuse large B-cell lymphoma: a multi-institutional study of KROG 17-02.

Jeong Won Lee, Dongryul Oh, Keun-Yong Eom, Jin Hee Kim, Woo Chul Kim, Mi Joo Chung, Jong Hoon Lee

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Clinical & experimental metastasis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma.Cancer imaging : the official publication of the International Cancer Imaging Society · 2023
    Article
  7. Article
  8. Article
  9. Prognostic value ofClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jeong Won LeeDepartment of Radiation Oncology, Catholic University of Daegu School of Medicine, Daegu, Republic of Korea.
Dongryul OhDepartment of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Keun-Yong EomDepartment of Radiation Oncology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Jin Hee KimDepartment of Radiation Oncology, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Republic of Korea.
Woo Chul KimDepartment of Radiation Oncology, Inha University Hospital, Inha University of Medicine, Inchon, Republic of Korea.
Mi Joo ChungDepartment of Radiation Oncology, Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea.
Jong Hoon LeeDepartment of Radiation Oncology, College of Medicine, St. Vincent's Hospital, The Catholic University of Korea, Seoul, Republic of Korea. koppul@catholic.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Korean Radiation Oncology Group (KROG) assessed the value of Deauville score (DS) on

Indexed as

AdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsChemoradiotherapyCyclophosphamideDisease-Free SurvivalDoxorubicinFemaleFluorodeoxyglucose F18Follow-Up StudiesHumansLymphoma, Large B-Cell, DiffuseMaleMiddle AgedNeoplasm Recurrence, LocalCyclophosphamideDoxorubicinFluorodeoxyglucose F18PrednisoneR-CHOP protocolRituximabVincristineDeauville scoreDiffuse large B-cell lymphomaPrognosisSurvival

Identifiers

PMID31555945

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.